Kevin Freeman

(Mr. Kevin Freeman)

Currently holds a position at Galectin Therapeutics Inc

Positions
Position Company Period
Independent Director Galectin Therapeutics Inc May 26, 2011 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-04-22 2024-04-22
B Purchase
2,500 +10.7%
2.98
7,450 USD 		2,500 +10.7% 2.98 7,450 USD
2022-10-31 2022-10-28
B Purchase
10,000 +15.4%
1.41
14,100 USD 		10,000 +15.4% 1.41 14,100 USD
2022-05-20 2022-05-19
B Purchase
5,000 +8.3%
1.33
6,650 USD 		5,000 +8.3% 1.33 6,650 USD
2022-04-18 2022-04-18
B Purchase
5,000 +9.1%
1.71
8,550 USD 		5,000 +9.1% 1.71 8,550 USD
2022-01-19 2022-01-19
B Purchase
5,000 +11.1%
1.96
9,806 USD 		5,000 +11.1% 1.96 9,806 USD
2021-12-15 2021-12-06
B Purchase
5,000 +11.1%
2.28
11,400 USD 		5,000 +11.1% 2.28 11,400 USD
2021-12-06 2021-12-06
B Purchase
5,000 +12.5%
2.34
11,700 USD 		5,000 +12.5% 2.34 11,700 USD
2021-11-01 2021-10-29
B Purchase
2,000 +5.3%
3.17
6,340 USD 		2,000 +5.3% 3.17 6,340 USD
2021-10-21 2021-10-21
B Purchase
2,000 +5.6%
3.19
6,380 USD 		2,000 +5.6% 3.19 6,380 USD
2021-10-19 2021-10-19
B Purchase
3,000 +9.1%
3.37
10,107 USD 		3,000 +9.1% 3.37 10,107 USD
2021-04-06 2021-04-05
B Purchase
5,000 +20.0%
2.04
10,200 USD 		5,000 +20.0% 2.04 10,200 USD
2020-09-09 2020-09-04
B Purchase
5,000 +25.0%
2.57
12,848 USD 		5,000 +25.0% 2.57 12,848 USD
2020-03-20 2020-03-19
B Purchase
6,000 +42.9%
1.64
9,844 USD 		6,000 +42.9% 1.64 9,844 USD
2019-09-09 2019-09-06
B Purchase
1,290 +13.3%
3.71
4,786 USD 		1,290 +13.3% 3.71 4,786 USD
2019-06-03 2019-05-31
B Purchase
1,426 +6.5%
4.28
6,103 USD 		1,426 +6.5% 4.28 6,103 USD
2019-06-03 2019-05-31
B Purchase
7,710 +385.5%
4.28
32,999 USD 		7,710 +385.5% 4.28 32,999 USD
2019-04-08 2019-04-05
B Purchase
500 +33.3%
4.73
2,365 USD 		500 +33.3% 4.73 2,365 USD
2019-02-11 2019-02-08
B Purchase
1,500 +inf%
4.29
6,428 USD 		1,500 +inf% 4.29 6,428 USD